Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value ChainAPI overviewPricingDocumentationPlan & billing
XSign in

Market Pulse

Daily · Sep 17, 2026 · data.go.kr + ECOS
KOSPI
6,715.41
-2.56 (-0.04%)
KOSDAQ
822.18
+6.20 (+0.76%)
KOSPI 200
1,058.27
-1.78 (-0.17%)
USD/KRW
1,382.20
Home›Reports›069620
069620KOSPI·Jul 31, 2026

Early Nabota shipments lift earnings

DAEWOONG PHARMAMirae Asset SecuritiesSeung-min Kim

Mirae Asset Securities published a company analysis report on DAEWOONG PHARMA (069620) titled "Early Nabota shipments lift earnings".

Summary
Covers DAEWOONG PHARMA (069620).
Covered stock
069620
DAEWOONG PHARMA
KOSPI · Company Analysis
Stock page →
More on 069620
Initiating Coverage: New Business Potential; Discount to NarrowKB Securities · May 27, 2026Efforts to streamline prescription drug channels underwayMirae Asset Securities · May 14, 2026Compelling valuationMirae Asset Securities · Nov 10, 2025Strong margin growthMirae Asset Securities · Feb 11, 2025
KOSPI
Early Nabota shipments lift earnings
Mirae Asset Securities
DAEWOONG PHARMA logo
Source
Mirae Asset Securities
PDF
Open report PDF →
Report facts
BrokerMirae Asset Securities
AnalystSeung-min Kim
Publication dateJul 31, 2026
RatingBuy
Target price-
CollectedSep 14, 2026
Use the publisher link for the complete report. Korean Tickers shows report metadata and a short overview.
Korean Tickers·Research reference for Korean listed companies.
API overviewPricingDocumentationPlan & billing
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy